newsfilter
← Latest News
GlobeNewswire·

Barinthus Bio Reports Second Quarter 2026 Financial Results and Updates on Corporate Developments

Proposed combination with Clywedog Therapeutics Inc. ("Clywedog") progressing towards closingCompleted enrollment of 42 planned subjects in the Phase 1 AVALON trial evaluating VTP-1000 in patients with celiac